BNP Paribas Financial Markets’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.9M Buy
44,895
+6,434
+17% +$1.85M 0.01% 962
2025
Q1
$11.9M Buy
38,461
+2,347
+6% +$724K 0.01% 935
2024
Q4
$12.7M Buy
36,114
+1,922
+6% +$678K 0.01% 856
2024
Q3
$12.3M Sell
34,192
-21,416
-39% -$7.67M 0.01% 744
2024
Q2
$17.7M Buy
55,608
+19,801
+55% +$6.31M 0.01% 595
2024
Q1
$8.23M Sell
35,807
-19,674
-35% -$4.52M 0.01% 823
2023
Q4
$12.2M Buy
55,481
+26,325
+90% +$5.79M 0.01% 634
2023
Q3
$6.59M Sell
29,156
-1,860
-6% -$420K 0.01% 752
2023
Q2
$6.85M Sell
31,016
-2,238
-7% -$494K 0.01% 772
2023
Q1
$7.45M Sell
33,254
-19,522
-37% -$4.37M 0.01% 756
2022
Q4
$14.7M Buy
52,776
+35,510
+206% +$9.87M 0.02% 536
2022
Q3
$3.62M Buy
17,266
+1,116
+7% +$234K 0.01% 1089
2022
Q2
$3.81M Sell
16,150
-21
-0.1% -$4.95K 0.01% 969
2022
Q1
$2.9M Sell
16,171
-19,933
-55% -$3.58M ﹤0.01% 1183
2021
Q4
$7.8M Buy
36,104
+6,370
+21% +$1.38M 0.01% 768
2021
Q3
$5.49M Sell
29,734
-17,528
-37% -$3.24M 0.01% 893
2021
Q2
$8.48M Buy
47,262
+32,568
+222% +$5.84M 0.01% 746
2021
Q1
$2.46M Sell
14,694
-67,582
-82% -$11.3M ﹤0.01% 1154
2020
Q4
$12.5M Buy
82,276
+71,406
+657% +$10.8M 0.02% 458
2020
Q3
$1.1M Sell
10,870
-56,020
-84% -$5.66M ﹤0.01% 1259
2020
Q2
$8.09M Buy
66,890
+37,471
+127% +$4.53M 0.01% 569
2020
Q1
$2.79M Sell
29,419
-45,557
-61% -$4.32M 0.01% 933
2019
Q4
$6.6M Buy
74,976
+58,725
+361% +$5.17M 0.01% 706
2019
Q3
$1.3M Sell
16,251
-13,579
-46% -$1.08M ﹤0.01% 1226
2019
Q2
$2.33M Sell
29,830
-27,793
-48% -$2.17M ﹤0.01% 956
2019
Q1
$6.76M Buy
57,623
+31,914
+124% +$3.75M 0.01% 578
2018
Q4
$2.8M Sell
25,709
-526
-2% -$57.3K 0.01% 747
2018
Q3
$3.35M Sell
26,235
-52,848
-67% -$6.76M 0.01% 888
2018
Q2
$8.95M Buy
79,083
+62,539
+378% +$7.08M 0.01% 574
2018
Q1
$1.86M Sell
16,544
-46,609
-74% -$5.24M ﹤0.01% 1003
2017
Q4
$9.34M Buy
63,153
+24,346
+63% +$3.6M 0.02% 450
2017
Q3
$4.55M Sell
38,807
-324,661
-89% -$38M 0.01% 767
2017
Q2
$47.2M Sell
363,468
-1,736
-0.5% -$225K 0.14% 129
2017
Q1
$49.4M Buy
365,204
+215,017
+143% +$29.1M 0.13% 154
2016
Q4
$21.5M Buy
150,187
+140,225
+1,408% +$20.1M 0.1% 164
2016
Q3
$1.18M Sell
9,962
-77,715
-89% -$9.18M ﹤0.01% 875
2016
Q2
$9.29M Sell
87,677
-30,517
-26% -$3.23M 0.04% 310
2016
Q1
$13.2M Sell
118,194
-64,590
-35% -$7.2M 0.06% 288
2015
Q4
$28.6M Buy
182,784
+89,722
+96% +$14.1M 0.07% 226
2015
Q3
$12.2M Buy
93,062
+13,711
+17% +$1.8M 0.03% 374
2015
Q2
$13.8M Buy
79,351
+21,981
+38% +$3.82M 0.04% 269
2015
Q1
$9.89M Buy
57,370
+6,150
+12% +$1.06M 0.03% 404
2014
Q4
$6.63M Buy
51,220
+2,233
+5% +$289K 0.02% 552
2014
Q3
$6.3M Sell
48,987
-38,218
-44% -$4.92M 0.01% 613
2014
Q2
$7.72M Sell
87,205
-12,489,447
-99% -$1.11B 0.01% 466
2014
Q1
$2.65B Buy
12,576,652
+12,508,648
+18,394% +$2.64B 2.06% 9
2013
Q4
$2.97B Sell
68,004
-12,544,537
-99% -$548B 2.17% 5
2013
Q3
$2.13B Sell
12,612,541
-43,242
-0.3% -$7.31M 1.55% 14
2013
Q2
$1.82B Buy
+12,655,783
New +$1.82B 1.29% 26